Cartesian Therapeutics Inc.

RNAC | NASDAQ

Price Alert Chart Builder DCF Calculator

$8.31

+$0.37 (+4.66%)

Sep 22, 2026, 11:33 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	n/a	78K	947K	452K	298K	1.1M	-759K	387K	33.45M	5.84M	8.27M	6.55M	5.25M	5.94M	16.8M	20.71M	39.27M	34M	29.94M	24.43M	19.66M	11.05M
Cost of Revenue	n/a	n/a	n/a	12.8M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	13M	17.78M	18.62M	607K	539K	498K	644K	n/a	n/a	n/a	n/a
Gross Profit	n/a	78K	947K	-12.35M	298K	1.1M	-759K	387K	33.45M	5.84M	8.27M	-6.45M	-12.53M	-12.69M	16.19M	20.17M	38.78M	33.36M	29.94M	24.43M	19.66M	11.05M
Operating Income	-29.16M	-26.5M	-21.94M	-21.07M	-21.81M	-21.89M	-26.73M	-17.58M	13.76M	-13.35M	-36.33M	-13.07M	-18.64M	-18.38M	-8.5M	-1.6M	13.86M	10.77M	4.08M	-1.97M	452K	-7.16M
Interest Income	1.1M	1.03M	1.27M	1.55M	1.75M	2.02M	7.39M	2.57M	1.2M	1.16M	940K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	15.77M	-39.18M	-101.77M	-35.9M	15.89M	-17.71M	-9.97M	-24.18M	13.84M	-56.82M	-196.66M	-9M	-11.39M	-21.66M	5.61M	-8.21M	8.6M	28.78M	12.38M	-2.07M	4.57M	-24.6M
Net Income	13.72M	-39.18M	-92.58M	-35.9M	15.89M	-17.71M	-10.25M	-24.18M	13.84M	-56.82M	-177.66M	-9M	-11.39M	-21.66M	5.89M	-7.89M	8.6M	28.78M	12.24M	-17.89M	4.57M	-24.6M
Selling & General & Admin	8.72M	7.11M	8.2M	7.72M	7.24M	8.32M	7.09M	6.56M	7.03M	9.45M	22.17M	6.61M	6.11M	5.7M	5.72M	5.23M	5.73M	4.89M	5.54M	5.45M	4.75M	5.2M
Research & Development	20.43M	19.46M	14.69M	13.8M	14.87M	14.67M	11.31M	11.4M	12.66M	9.74M	22.43M	13M	17.78M	18.62M	18.97M	16.54M	19.18M	17.69M	20.32M	20.95M	14.46M	13M
Other Expenses	n/a	n/a	n/a	-12.8M	n/a	n/a	7.58M	n/a	n/a	n/a	n/a	-13M	-17.78M	-18.62M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	29.16M	26.58M	22.89M	8.72M	22.11M	22.99M	25.97M	17.96M	19.69M	19.19M	44.6M	6.61M	6.11M	5.7M	24.68M	21.77M	24.92M	22.58M	25.86M	26.4M	19.21M	18.21M
Interest Expense	852K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.27M	752K	808K	807K	802K	715K	707K	711K	711K	711K	711K
Selling & Marketing Expenses	n/a	n/a	n/a	1.13M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	968K	968K	841K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	29.16M	26.58M	22.89M	21.52M	22.11M	22.99M	25.97M	17.96M	19.69M	19.19M	44.6M	19.62M	23.89M	24.32M	25.29M	22.31M	25.41M	23.23M	25.86M	26.4M	19.21M	18.21M
Income Tax Expense	n/a	n/a	-9.19M	n/a	n/a	n/a	287K	n/a	n/a	n/a	-19M	n/a	n/a	n/a	-288K	-321K	n/a	n/a	138K	15.83M	n/a	n/a
Shares Outstanding (Basic)	29.47M	26.86M	25.97M	26M	25.98M	25.9M	25.91M	21.47M	16.72M	5.41M	5.17M	5.16M	5.11M	5.11M	4.83M	5.1M	4.95M	4.14M	3.84M	3.84M	3.15M	3.08M
Shares Outstanding (Diluted)	29.86M	26.86M	25.97M	26M	26.45M	25.9M	25.91M	21.47M	17.79M	5.41M	5.17M	5.16M	5.11M	5.11M	4.83M	5.1M	4.95M	4.14M	3.84M	3.84M	3.37M	3.08M
EPS (Basic)	0.47	-1.46	-3.56	-1.38	0.61	-0.68	-0.07	-1.13	0.58	-10.50	-41.56	-1.74	-2.23	-4.24	1.16	-1.50	1.74	6.95	3.12	-4.66	1.21	-6.66
EPS (Diluted)	0.46	-1.46	-3.46	-1.38	0.60	-0.68	-0.07	-1.13	0.54	-10.50	-41.56	-1.74	-2.23	-4.24	1.16	-1.55	1.74	6.77	2.96	-4.66	1.13	-6.66
EBITDA	17.42M	-38.57M	-101.16M	-35.3M	16.48M	-16.55M	-9.48M	-23.9M	14.03M	-56.64M	-196.39M	-7.54M	-10.46M	-20.65M	7.02M	-6.87M	9.81M	30.13M	13.41M	-733K	5.86M	-23.41M
EBIT	16.62M	-39.18M	-101.77M	-35.9M	15.89M	-17.71M	-9.97M	-24.18M	13.84M	-56.82M	-196.66M	-7.73M	-10.64M	-20.86M	6.41M	-7.41M	9.32M	29.49M	13.09M	-1.36M	5.28M	-23.89M
Depreciation & Amortization	800K	615K	608K	606K	589K	1.16M	486K	286K	196K	183K	272K	189K	176K	206K	607K	539K	498K	644K	323K	622K	582K	479K